Funding · Company
Aurion Biotech, Inc.
Seattle, WABiotech & Pharma
Aurion Biotech, Inc. of Seattle, WA has disclosed $81M across 2 Form D offerings filed with the SEC between Apr 21, 2022 and Apr 25, 2022.
$81M
Total disclosed
2
Form D offerings
2021
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$55M
Form D · Apr 21, 2022 ↗
Q2 2022
· target $120M
Filing details
HeadquartersSeattle, WAIndustryBiotech & Pharma (Biotechnology)Incorporated2021SEC CIK0001924356Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →